Regeneron has formed a corporate venture capital unit with $100 million a year to invest over the next five years in “biopharmaceutical, healthcare, and health technology” start-ups.
Viewing entries tagged
Health Technology
"Having good market intelligence is no longer optional in this day and age"
Rakesh Pabbi - Senior Partner
Viewing entries tagged
Health Technology
Regeneron has formed a corporate venture capital unit with $100 million a year to invest over the next five years in “biopharmaceutical, healthcare, and health technology” start-ups.